Development of a solid dosage platform for the oral delivery of bilayer vesicles

Jitinder S. Wilkhu, Sarah E. McNeil, David E. Anderson, Marc Kirchmeier, Yvonne Perrie

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Within this work, we develop vesicles incorporating sub-unit antigens as solid dosage forms suitable for the oral delivery of vaccines. Using a combination of trehalose, dextran and mannitol, freeze-dried oral disintegrating tablets were formed which upon rehydration release bilayer vesicles incorporating antigen. Initial studies focused on the optimisation of the freeze-dry cycle and subsequently excipient content was optimised by testing tablet hardness, disintegration time and moisture content. The use of 10 % mannitol and 10 % dextran produced durable tablets which offered strong resistance to mechanical damage yet appropriate disintegration times and dispersed to release niosomes-entrapping antigen. From these studies, we have formulated a bilayer vesicle vaccine delivery system as rapid disintegrating tablets and capsules.
LanguageEnglish
Pages71-77
Number of pages7
JournalEuropean Journal of Pharmaceutical Sciences
Volume108
Early online date12 Jun 2017
DOIs
Publication statusPublished - 15 Oct 2017

Fingerprint

Tablets
Mannitol
Dextrans
Antigens
Vaccines
Trehalose
Fluid Therapy
Excipients
Dosage Forms
Hardness
Liposomes
Capsules

Keywords

  • liposomes
  • niosomes
  • vesicles
  • oral disintegrating tablets
  • oral vaccines
  • mannitol
  • dextran

Cite this

Wilkhu, Jitinder S. ; McNeil, Sarah E. ; Anderson, David E. ; Kirchmeier, Marc ; Perrie, Yvonne. / Development of a solid dosage platform for the oral delivery of bilayer vesicles. In: European Journal of Pharmaceutical Sciences. 2017 ; Vol. 108. pp. 71-77.
@article{48864cbac2064300a7ddd2a2a7ad0987,
title = "Development of a solid dosage platform for the oral delivery of bilayer vesicles",
abstract = "Within this work, we develop vesicles incorporating sub-unit antigens as solid dosage forms suitable for the oral delivery of vaccines. Using a combination of trehalose, dextran and mannitol, freeze-dried oral disintegrating tablets were formed which upon rehydration release bilayer vesicles incorporating antigen. Initial studies focused on the optimisation of the freeze-dry cycle and subsequently excipient content was optimised by testing tablet hardness, disintegration time and moisture content. The use of 10 {\%} mannitol and 10 {\%} dextran produced durable tablets which offered strong resistance to mechanical damage yet appropriate disintegration times and dispersed to release niosomes-entrapping antigen. From these studies, we have formulated a bilayer vesicle vaccine delivery system as rapid disintegrating tablets and capsules.",
keywords = "liposomes, niosomes, vesicles, oral disintegrating tablets, oral vaccines, mannitol, dextran",
author = "Wilkhu, {Jitinder S.} and McNeil, {Sarah E.} and Anderson, {David E.} and Marc Kirchmeier and Yvonne Perrie",
year = "2017",
month = "10",
day = "15",
doi = "10.1016/j.ejps.2017.06.014",
language = "English",
volume = "108",
pages = "71--77",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",

}

Development of a solid dosage platform for the oral delivery of bilayer vesicles. / Wilkhu, Jitinder S.; McNeil, Sarah E.; Anderson, David E.; Kirchmeier, Marc; Perrie, Yvonne.

In: European Journal of Pharmaceutical Sciences, Vol. 108, 15.10.2017, p. 71-77.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development of a solid dosage platform for the oral delivery of bilayer vesicles

AU - Wilkhu, Jitinder S.

AU - McNeil, Sarah E.

AU - Anderson, David E.

AU - Kirchmeier, Marc

AU - Perrie, Yvonne

PY - 2017/10/15

Y1 - 2017/10/15

N2 - Within this work, we develop vesicles incorporating sub-unit antigens as solid dosage forms suitable for the oral delivery of vaccines. Using a combination of trehalose, dextran and mannitol, freeze-dried oral disintegrating tablets were formed which upon rehydration release bilayer vesicles incorporating antigen. Initial studies focused on the optimisation of the freeze-dry cycle and subsequently excipient content was optimised by testing tablet hardness, disintegration time and moisture content. The use of 10 % mannitol and 10 % dextran produced durable tablets which offered strong resistance to mechanical damage yet appropriate disintegration times and dispersed to release niosomes-entrapping antigen. From these studies, we have formulated a bilayer vesicle vaccine delivery system as rapid disintegrating tablets and capsules.

AB - Within this work, we develop vesicles incorporating sub-unit antigens as solid dosage forms suitable for the oral delivery of vaccines. Using a combination of trehalose, dextran and mannitol, freeze-dried oral disintegrating tablets were formed which upon rehydration release bilayer vesicles incorporating antigen. Initial studies focused on the optimisation of the freeze-dry cycle and subsequently excipient content was optimised by testing tablet hardness, disintegration time and moisture content. The use of 10 % mannitol and 10 % dextran produced durable tablets which offered strong resistance to mechanical damage yet appropriate disintegration times and dispersed to release niosomes-entrapping antigen. From these studies, we have formulated a bilayer vesicle vaccine delivery system as rapid disintegrating tablets and capsules.

KW - liposomes

KW - niosomes

KW - vesicles

KW - oral disintegrating tablets

KW - oral vaccines

KW - mannitol

KW - dextran

UR - http://www.sciencedirect.com/science/journal/09280987?sdc=1

U2 - 10.1016/j.ejps.2017.06.014

DO - 10.1016/j.ejps.2017.06.014

M3 - Article

VL - 108

SP - 71

EP - 77

JO - European Journal of Pharmaceutical Sciences

T2 - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

ER -